SCHEMBL6632277

SCHEMBL6632277

c1ccc(CNc2nnn[nH]2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.49
HSD17B10 Q99714 1/20 0.49
ALDH1A1 P00352 2/20 0.47
RAB9A P51151 2/20 0.47
TP53 P04637 1/20 0.47
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
POLB P06746 1/20 0.44
MMP3 P08254 1/20 0.44
PIM1 P11309 1/20 0.43
RECQL P46063 1/20 0.43
LMNA P02545 2/20 0.42
HTT P42858 2/20 0.42
XDH P47989 1/20 0.42
FABP1 P07148 1/20 0.42
FABP6 P51161 1/20 0.42
HCAR2 Q8TDS4 1/20 0.41
PI4KA P42356 1/20 0.41
PI4K2B Q8TCG2 1/20 0.41
PI4K2A Q9BTU6 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4064447 0.98 SMN1; SMN2 (0.47) SMN1; SMN2HSD17B10ALDH1A1RAB9ATP53
SCHEMBL5603848 0.90 ALDH1A1 (0.43) SMN1; SMN2HSD17B10ALDH1A1RAB9ATP53
Hydrochloric Acid SCHEMBL6791179 0.81 L3MBTL1 (0.50) SMN1; SMN2ALDH1A1RAB9AMEN1KMT2A
SCHEMBL9204216 0.80 ELANE (0.43) PIM1HTT
SCHEMBL18541915 0.76 HTT (0.52) SMN1; SMN2RAB9ATP53MEN1KMT2A
SCHEMBL8824655 0.75 MAPT (0.52) ALDH1A1MEN1KMT2APOLB
SCHEMBL2528923 0.71 ALDH1A1 (0.54) HSD17B10ALDH1A1MEN1KMT2AGAA
SCHEMBL12114155 0.71 APP (0.45) LMNAPI4KAPI4K2BPI4K2API4KB
SCHEMBL2836274 0.71 MEN1 (0.46) SMN1; SMN2HSD17B10ALDH1A1RAB9ATP53
SCHEMBL14868919 0.70 MEN1 (0.55) SMN1; SMN2HSD17B10ALDH1A1RAB9ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2365809-B1 PYRAZINOPYRAZINES AND DERIVATIVES AS KINASE INHIBITORS ARIAD PHARMA INC (US) 2018-07-18 EP disclosed
EP-1490343-A1 NEW ARYL IMIDAZOLES AND RELATED COMPOUNDS AS C5A RECEPTOR MODULATORS Neurogen Corporation (US) 2004-12-29 EP disclosed
WO-2003082829-A1 NEW ARYL IMIDAZOLES AND RELATED COMPOUNDS AS C5A RECEPTOR MODULATORS NEUROGEN CORPORATION (US) 2003-10-09 WO disclosed
EP-0829480-B1 Tetrazolyl-substituted quinuclidines as substance P antagonists PFIZER (US) 2000-12-20 EP disclosed
US-5939434-A Tetrazolyl-substituted quinuclidines as substance P antagonists PFIZER PHARMACEUTICALS INC. (JP) 1999-08-17 US disclosed
EP-0829480-A2 Tetrazolyl-substituted quinuclidines as substance P antagonists PFIZER INC. (US) 1998-03-18 EP disclosed